Clinical Trial Update: Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluated the safety and efficacy of two docetaxel-based regimens plus bevacizumab as adjuvant therapy for node-positive or high-risk node…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab) (bevacizumab)
• Taxotere (docetaxel) (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2011-11-04